The Riddell Centre is comprised of three interrelated research prioities critical for bench-to-bedside-and-back cancer immunotherapy research: Discovery and Innovation, Biomanufacturing, and Clinical Research and Translation. The ultimate and future goal of our research centre is to move our immunotherapies into the health system as standard of care therapeutics.